Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetInterleukin-1 receptor-associated kinase 4
LigandBDBM50544200
Substrate/Competitorn/a
Meas. Tech.ChEMBL_1991895 (CHEMBL4625630)
IC50 12±n/a nM
Citation Nair, SKumar, SRPaidi, VRSistla, RKantheti, DPolimera, SRThangavel, SMukherjee, AJDas, MBhide, RSPitts, WJMurugesan, NDudhgoankar, SNagar, JSubramani, SMazumder, DCarman, JAHolloway, DALi, XFereshteh, MPRuepp, SPalanisamy, KMariappan, TTMaddi, SSaxena, AElzinga, PChimalakonda, ARuan, QGhosh, KBose, SSack, JYan, CKiefer, SEXie, DNewitt, JASaravanakumar, SPRampulla, RABarrish, JCCarter, PHHynes, J Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. ACS Med Chem Lett11:1402-1409 (2020) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
Interleukin-1 receptor-associated kinase 4
Name:Interleukin-1 receptor-associated kinase 4
Synonyms:IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:Protein
Mol. Mass.:51519.08
Organism:Homo sapiens (Human)
Description:Q9NWZ3
Residue:460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALL
QTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITV
QQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNF
DERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC
QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGIN
FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL
RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND
ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50544200
n/a
NameBDBM50544200
Synonyms:CHEMBL4644871
TypeSmall organic molecule
Emp. Form.C19H23N5OS
Mol. Mass.369.484
SMILESCCCNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1NC(C)C
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: